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Abstract
Tissue-engineered heart valves are proposed as novel viable replacements granting longer durability and growth potential.
However, they require extensive in vitro cell-conditioning in bioreactor before implantation. Here, the propensity of non-
preconditioned decellularized heart valves to spontaneous in body self-regeneration was investigated in a large animal
model. Decellularized porcine aortic valves were evaluated for right ventricular outflow tract (RVOT) reconstruction in
Vietnamese Pigs (n = 11) with 6 (n = 5) and 15 (n = 6) follow-up months. Repositioned native valves (n = 2 for each time) were
considered as control. Tissue and cell components from explanted valves were investigated by histology, immunohisto-
chemistry, electron microscopy, and gene expression. Most substitutes constantly demonstrated in vivo adequate
hemodynamic performances and ex vivo progressive repopulation during the 15 implantation months without signs of
calcifications, fibrosis and/or thrombosis, as revealed by histological, immunohistochemical, ultrastructural, metabolic and
transcriptomic profiles. Colonizing cells displayed native-like phenotypes and actively synthesized novel extracellular matrix
elements, as collagen and elastin fibers. New mature blood vessels, i.e. capillaries and vasa vasorum, were identified in
repopulated valves especially in the medial and adventitial tunicae of regenerated arterial walls. Such findings correlated to
the up-regulated vascular gene transcription. Neoinnervation hallmarks were appreciated at histological and ultrastructural
levels. Macrophage populations with reparative M2 phenotype were highly represented in repopulated valves. Indeed, no
aspects of adverse/immune reaction were revealed in immunohistochemical and transcriptomic patterns. Among
differentiated elements, several cells were identified expressing typical stem cell markers of embryonic, hematopoietic,
neural and mesenchymal lineages in significantly higher number and specific topographic distribution in respect to control
valves. Following the longest follow-up ever realized in preclinical models, non-preconditioned decellularized allogeneic
valves offer suitable microenvironment for in vivo cell homing and tissue remodeling. Manufactured with simple, timesaving
and cost-effective procedures, these promising valve replacements hold promise to become an effective alternative,
especially for pediatric patients.
Citation: Iop L, Bonetti A, Naso F, Rizzo S, Cagnin S, et al. (2014) Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-
Term Preclinical Evaluation. PLoS ONE 9(6): e99593. doi:10.1371/journal.pone.0099593
Editor: Beatriz Pelacho, Foundation for Applied Medical research, Spain
Received January 31, 2014; Accepted May 16, 2014; Published June 18, 2014
Copyright:  2014 Iop et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Italian grants Azione Biotech III and RSF 286/08 (Veneto Region) supported this research. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: laura.iop@unipd.it
. These authors contributed equally to this work.
Introduction
Bioprosthetic and mechanical substitutes are currently unique
therapeutic options for the rising concern of heart valve disease,
affording however time-limited or unsatisfactory biocompatibility
[1].
Implanted bioprostheses degenerate following calcific nucle-
ation on cell remnants, interesting fragmented collagen/elastin
fibers and/or depending on the mineralization potential of
glutaraldehyde (GA) residues [2–4]. GA treatment stabilizes
extracellular matrix (ECM) against chemical/enzymatic degrada-
tion and shields xenogeneic cell epitopes in porcine or bovine
bioprostheses [5]. Though, GA cytotoxicity hinders cell viability in
valve tissues [6]. Additionally, in vivo tissue fatigue may induce GA-
coating microfenestrations with xenoantigen exposure and in-
creasing titers of specific IgGs/IgMs early after implantation [7,8].
During the last decades, several tissue-engineered heart valves
(TEHVs) have been tested as alternative surgical solutions to non-
viable bioprostheses. Naturally endowed with a tridimensional
ECM architecture for satisfactory heart valve physiology, decel-
lularized native tissues are used as scaffolds to be cell-seeded and
stimulated in bioreactors for the achievement of mature bioengi-
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neered replacements [1]. However, the manufacturing phases for
their production are arduous to control and time-consuming.
The exceptional TEHV approach of guided tissue regeneration
sidesteps in vitro conditionings, conceiving the body as physiolog-
ical bioreactor: positive hemodynamic evaluations of such a
regenerative concept have been already reported in sheep models
within short/mid-term follow-ups and recently in the clinics with
no mortality up to 6 years [9–12].
So far, only two decellularized, GA-devoid porcine matrices
have been evaluated in patients with great expectation on post-
implantation tissue remodelling. Both applied for RVOT recon-
struction, Synergraft valves were implanted in 4 children in 2001
with catastrophic early-term failure, while controversial immuno-
logical findings were disclosed for Matrix P ones, used since 2002
in nearly 200 subjects [13–17].
Residual xenoantigens in incompletely decellularized xenoge-
neic grafts might be responsible for hyperacute rejection [13]. In
novel TEHVs, it will be mandatory to assess retained biohazard-
ous agents, such as alpha-gal, through specific assays.
TRICOL treatment combines osmotic shock, Triton X100/
Sodium Cholate detergents and endonucleases, resulting in
complete tissue decellularization, alpha-gal xenoantigens removal
and preservation of original scaffold architecture and valve
performance [18–22].
Following these preliminary in vitro validations, TRICOL-
treated aortic valves were implanted in Vietnamese pigs (VPs) as
allogeneic RVOT replacements with favourable haemodynamic
assessments up to 15 months [23].
The present study focuses on the ex vivo evaluation of valve re-
colonization and demonstrates effective tissue regeneration of
decellularized heart valve scaffolds by recipient’s cells after this
long-term follow-up.
Materials and Methods
1. Preparation of Decellularized Valve Scaffolds
Aortic heart valves were isolated from 3–4 months old common
breeding piglets and submitted to TRICOL decellularization
treatment [18–23]. Briefly, hearts were obtained in local abattoirs
and maintained in antibiotics/antimycotic-complemented cold
saline solution until further processing (100 U/mL penicillin,
100 mg/mL streptomycin and 250 mg/mL amphotericin B).
After isolation in aseptic conditions, aortic valvulated conduits
were decellularized by alternated treatment with hypo- or
hypertonic solutions, Triton X100 and sodium cholate detergents,
followed by incubation with the aspecific endonuclease Benzonase
(Novagen, EMD Millipore, San Diego, CA) for complete removal
of nuclear remnants. Effective decellularization was assessed by
classic histology, DNA biochemical quantification and nuclear
counterstaining with Hoechst (Hoechst 33258; Sigma) as else-
where reported [23]. The coronary arteries originating from the
aortic root were closed through suture and their ostia were
trimmed in order to use the allogeneic conduit as pulmonary valve
substitute. Further disinfecting treatment was performed before
valve implantation by four 24-hours cycles with fresh antibiotic-
antimycotic cocktail as elsewhere described [19].
2. In vivo Implantation and Ex vivo Cell and Tissue
Analyses on Grafted Heart Valves
The Italian Ministry of Health (IACUC equivalent) authorized
the University of Padua to use VPs for the experimental purposes
of this study (27/08 C16 project), conforming to D. Lgs. 116 (art.
12; 27.01.1992) and to ISO 10993-2 principles. A total of 20 VPs,
provided by CISRA Institute (120TO025-ASL 3 Collegno,
Torino, Italy), were housed in groups and after their arrival, at
least one week was left for acclimation.
General welfare of VPs was assessed daily and was considered
satisfactory if body condition score, social, alimentary and
locomotory behavior were found normal.
If any clinical (i.e. dyspnea, depression, anorexia, weight loss) or
behavioral (i.e. separation from the social group, lack of normal
curiosity) abnormality was observed, a complete clinical and
cardiological evaluation was performed. In case of severe illness or
heart failure, pre-term euthanasia was induced.
Five out of 20 animals were not included in the study due to
intra-operative death caused by ventricular fibrillation or arterial
embolization, iatrogenic complications after surgery or post-
intervention endocarditis. TRICOL-decellularized, allogeneic
aortic valves were used for RVOT reconstruction in 11 animals
(group A; n= 5 and n= 6 for 6 and 15 months respectively). In
sham VPs (n= 2 for each considered evaluation time), the
pulmonary valves were resected and re-implanted in the same
position. More detailed information about animal husbandry,
clinical management, valve implantation and instrumental follow-
up have been reported elsewhere [23].
At any experimental sacrifice time foreseen by the study design,
each VP was sedated with midazolam (0.3 mg/kg), medetomidine
(15 mg/kg) and ketamine (10 mg/kg), administered into the neck
muscles, using a 3.5 inch spinal needle connected to a syringe by
the means of an extension line (162.561500 mm) (Prolex
extension line, Emiltek srl, Mirandola, Italy). Anaesthesia was
induced with isoflurane in oxygen via facemask. Before tracheal
intubation, the larynx was desensitized with one dose (1 ml) of 2%
lidocaine. Anesthesia was maintained with isoflurane in oxygen,
administered via a circular breathing system and alfentanil 20 mg
Kg21 was administered as a loading dose, followed by 1–1.5 mg
Kg21 min21 as constant rate infusion. Once thoracotomy was
accomplished, each VP was suppressed by an intravenous injection
of a mixture of embutramide, mebenzonium iodide and tetracaine
hydrochloride (Tanax, Intervet Italia, Segrate, Italy) at 0.3 ml per
Kg of body weight, just before explanting engrafted valves.
In order to evaluate the occurrence of in vivo regeneration, each
TRICOL aortic graft, used to reconstruct the RVOT in Group A,
was harvested at 6 or 15 months under sterile conditions together
with the proximal and distal anastomosed recipient’s tissues
(RVOT muscle portion and native pulmonary artery segment). A
longitudinal cut at the level of the cusp commissures was
performed to divide the explanted graft in three sectors, each
comprising the corresponding leaflet, the Valsalva sinus, the
allograft wall and the distal anastomoses. Re-implanted pulmonary
roots in Group B were isolated and subdivided as above-
mentioned.
2.1 Histology and immunohistochemistry. Histological
analyses were performed on thin paraffin sections by standard
Haematoxylin and Eosin and Masson’s staining, Alcyan-PAS for
glycosaminoglycan detection (GAGs), Heidenhain’s Azan tri-
chrome to analyze collagen fibres, elastic van Gieson for the
evaluation of elastic fibres and von Kossa (Sigma) to investigate the
presence of calcifications. Observations were accomplished using
an Olympus microscope BX51 (Olympus Corporation, Tokyo,
Japan).
For immunolocalization experiments, tissues underwent OCT
inclusion, snap-freezing and further serial cryostat sectioning (8–
9 mm-thick sections). For immunohistochemical experiments using
paraffin-embedded tissue samples, deparaffinised thin sections (4–
5 mm) were subjected to heat-induced antigen retrieval performed
according to standard protocols. A pre-treatment in citrate buffer
using a Rapid Microwave Histoprocessor (RHS Milestone,
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Sorisole, Italy), followed by washes in phosphate buffer and
20 min-incubation in PBS containing 2% milk powder and 0,2%
Triton X-100 was carried out.
The following primary antibodies were used:
N Pig CD45 (CD45; AbD Serotec, Oxon, UK), Pig T-cell
receptor d (VMRD Inc., Pullman, IL), B-cells (Abcam,
Cambridge, UK), CD68 (Dako, Dakopatts, Denmark), IL-10
(Abcam), Natural Killers (NK; Abcam) and Mast Cell (Abcam)
for inflammatory/immune responses;
N Osteocalcin (OC; Abcam) for calcifying cells;
N Von Willebrand factor (vWf; Dako) and CD31 (Santa Cruz
Biotechnology, Santa Cruz, CA) for endothelial cells (ECs);
N Smooth muscle actin (SMA; Sigma, St. Louis, MO),
osteopontin (OPN; Abcam), vimentin (Dako), type A non-
muscle myosin heavy chains (MyHCApla1; [24]), smoothelin
(Abcam), calponin (Sigma) and smooth muscle myosin (SM-
MyHC; [24]) for interstitial valve cells (VICs) and smooth
muscle cells (SMCs);
N Pro-collagen I (Developmental Studies Hybridoma Bank, Iowa
City, IA), collagen I (Sigma) and elastin (Sigma) for ECM;
N SSEA4 (Chemicon, Temecula, CA) and OCT4 (Santa Cruz)
for embryonic stem cells;
N CD34 (Dako) and CD117 (Santa Cruz) for haematopoietic
stem cells;
N CD29 (VMRD Inc.), CD90 (Cymbus, Chandlers Ford, UK)
and CD105 (Abcam) for mesenchymal stem cells;
N Nerve Growth Factor receptor (NGFr, Abcam), Nestin
(Abcam) and Glial fibrillary acidic protein (GFAP; Chemicon)
and Protein Gene Product 9.5 (PGP 9.5; UltraClone Limited,
Wellow Isle of Wight, UK) for neural stem cells and neuronal
cells.
Primary antibody binding was revealed through HRP-conju-
gated anti-mouse and anti-rabbit IgGs (Dako) as secondary
antibodies. Controls were incubated with mouse or rabbit non-
immune IgGs (respectively Sigma and Dako) instead of the
primary antibodies. The 3-amino-9-ethylcarbazole (AEC; Sigma)
represented the substrate used for revelation. Then, nuclear
counterstaining was carried out with Harris’s haematoxylin
(Sigma).
A Leica light microscope (Leica, Wetzlar, Germany), connected
to a Leica DC300 digital camera, was used for antigen distribution
evaluation and image recording. Before photographic acquisition,
four microscopic fields (ROI=0,0374 mm2) were selected as
representative of the analyzed sample. For each considered
antigen, equivalent areas of interest were examined. Antigen
distribution was computed as mean percentage 6 deviation
standard using ImageJ software (http://rsbweb.nih.gov/ij).
2.2 Primary cell cultures. Explanted graft wall specimens
and corresponding leaflets were sterile kept at +4uC until further
processing. Adventitial, medial and valve interstitial primary cells
were obtained by pre-digested explant culture, as described
elsewhere [25]. Adventitia was carefully stripped from the vessel,
minced and cultured in complete medium containing a-MEM
(Sigma), 20% FBS (Gibco, Carlsbad, CA), 1% L-Glutamine and
1% Penicillin- Streptomycin (Sigma). Leaflet surfaces and vessel
lumen were scraped to remove the endothelium, minced in
fragments of about 2–3 mm3, incubated with a sterile-filtered
digestion solution composed of collagenase I (125 units/ml;
Sigma), elastase (8 units/ml; Sigma) and soybean trypsin inhibitor
(0,375 mg/ml; Sigma) for 30 minutes at 37uC. Fragments were
collected in an OPTILUX non-tissue culture Petri dish (Falcon
BD Bioscience, San Diego, CA) and cultured in the complete
medium described before. Cells spread from pre-digested
fragments after 7–10 days.
Morphological aspects of different primary cultures were
observed with a phase contrast Leica DM IRB microscope
connected to a Canon Power shot S40 camera.
After first passaging, cells were plated onto coverslips and
analyzed immunohistochemically after fixation in 2% p-formal-
dehyde in PBS pH 7.2. A double indirect immunofluorescence was
performed on p2 different cell types by incubating with anti-SMA,
FITC-conjugated (clone 1A4; Sigma), and the following antibodies
directed versus CD45, MyHCApla1, smoothelin, calponin, SM-
MyHC, OPN, OC, SSEA4, OCT4, CD29 and CD90. Alexa
Fluor 594-conjugated goat Fab’ to mouse IgGs (Molecular Probes,
Carlsbad, CA) and anti-rabbit TRITC-conjugated goat IgGs
(Sigma) were used as secondary antibodies. Cell nuclei were
identified by Hoechst staining.
Antigen distribution was studied in four microscopic fields
(corresponding to 0,0374 mm2) using a Zeiss Axioplan epifluor-
escence microscope (Zeiss MicroImaging GmbH, Go¨ttingen,
Germany) and images were acquired using a Leica DC300F
digital camera. ImageJ software was used to quantify cell
expression, further elaborated as mean percentage 6 deviation
standard.
2.3 Cell survival. Cell mitotic events were studied with a
specific marker of cell proliferation, i.e. Phospho-Histone 3 (PH3;
Ser 10 Upstate, Lake Placid, NY). Antibody binding was indirectly
revealed with an anti-rabbit HRP-conjugated secondary antibody
and AEC as substrate or, for quantification experiments, using
anti-rabbit TRITC-conjugated goat IgGs. Haematoxylin or
Hoechst were used to counterstain nuclei.
A TUNEL-based in situ detection kit was applied to evaluate
DNA fragmentation in apoptotic cells (ApopTag Plus Fluorescein/
Peroxidase In Situ Apoptosis Detection Kits; Chemicon) following
the manufacturer’s instructions.
Observations and photographic recordings were collected by
means of Zeiss Axioplan epifluorescence microscope or AxioIma-
ger photomicroscope (Zeiss). Quantification of positive cell events
in four microscopic fields (corresponding to 0,0374 mm2) was
obtained by means of ImageJ software and expressed as mean
percentage 6 deviation standard.
2.4 Scanning Electron Microscopy (SEM). Specimens
were fixed with 2,5% glutaraldehyde and 2,5% formaldehyde in
0,1 M phosphate buffer. After progressive dehydration with
ethanol solutions from 20% to 100%, they were critical point dried
and vacuum metalized. A Jeol JSM 6490 microscope (Jeol,
Peabody, MA) was utilized for observation and recording. Images
were elaborated by Photoshop CS2 software to ease the
visualization of different ECM components and cell elements:
basal lamina/ECM, ECs, endothelial microvilli and red cells were
colored in green, blue, purple and red respectively.
2.5 Transmission Electron Microscopy (TEM). Tissues,
fixed with 2,5% glutaraldehyde and 2,5% formaldehyde in 0,1 M
phosphate buffer, were rinsed with the same buffer, treated with
2% osmium tetraoxide (Agar Scientific Ltd, Essex, UK), dehy-
drated in graded ethanol solutions and embedded in Araldite/
Epon. Semithin sections were conventionally stained with 1%
toluidine blue. Thin sections were collected on formvar-coated
261-mm-slot copper grids and contrasted with uranyl acetate and
lead citrate. Observations and photographic records were realized
using a Philips CM12/STEM electron microscope (Philips,
Eindhoven, The Netherlands).
2.6 Microarray analyses. Tissue samples were stored in
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RNA and small RNAs were extracted independently from each
tissue sample with TRIzol reagent (Invitrogen, Carlsbad, CA) in
association with PureLink miRNA isolation kit (Invitrogen) and
flashPAGE fractionator system (Ambion). Briefly, a tissue amount
of approximately 200 mg was homogenized in 3,5 ml of TRIzol
with a tissue homogenizer (IKA Werke, Staufen, Germany). After
chloroform addition and centrifugation, the colorless upper
aqueous RNA containing phase was mixed with 96–100% ethanol
to a final concentration of 35% ethanol and loaded to PureLink
membrane to separate total and small RNAs following the
manufacturer’s instructions. Total and small RNAs were quan-
tized using Nanodrop ND 1000 spectrophotometer (Thermo
Fisher Scientific, Waltham, MA). Total RNA samples were tested
for quality on Agilent Bioanalyzer 2100 using RNA 6000 Nano
LabChip (Agilent, Santa Clara, CA): an average value of 7 as
RNA Integrity Number (RIN) was set to proceed in further
analyses. MicroRNAs (MiRNAs or MiRs) were purified from small
RNAs through flashPAGE after testing for their presence with the
2100 Small RNA (Agilent).
For Messenger RNA gene expression, Ensembl transcripts (Ver.
56) and UniGene (Ver. 38) pig sequences were used to develop a
dedicated microarray platform (90 K CombiMatrix, Irvine, CA)
in order to monitor mRNA expression (GEO ID: GPL13259). A
total RNA quantity of 1 mg was linearly amplified and labelled
with the addition of biotinylated nucleotides according to the
Ambion MessageAmp II aRNA Amplification kit (Ambion).
Biotinylated UTPs were incorporated into the aRNA during the
in vitro transcription reaction. Following purification, 18 mg of
aRNA was fragmented using the Ambion Fragmentation Kit
(Ambion). Intact and fragmented aRNAs were tested on Agilent
Bioanalyzer 2100 using RNA 6000 Nano LabChip. Fragmented
aRNA was hybridized to pre-hybridized 90 K Combimatrix
microarrays.
Images of hybridized microarray were analyzed for fluorescence
signal quantification using the Combimatrix imaging software.
Negative control probes were introduced in the microarrays and
used to calculate the background value (filter). A Gene Ontology
(GO) analysis was performed using FunNet transcriptional
network analysis [26,27].
For evaluation of miRNA expression, dedicated microarrays
composed of specific probes for miRNAs and associated
background probes (GEO ID: GPL13322) were developed.
150 ng of miRNA were hybridized to microarray platform to
perform RAKE experiments in duplicates. Quantization of
miRNA concentration was based on a specific titration curve
obtained from the signals of spike RNA introduced in the reaction
mixture. A regulatory network was produced also according to
gene interactions retrieved from STRING database [28] and
visualized through Cytoscape [29].
All microarray data have been deposited at GEO database with
accession number GSE27853.
3. Statistical analysis
All data regarding the protein expression analyses are expressed
as means 6 SD. Statistical differences between the allografted
aortic tissues and the repositioned pulmonary valves were
determined using Student’s paired t-tests. Statistical significance
was considered for p,0.05. For gene expression investigation, raw
data obtained from the fluorescence signal quantification of
microarrays were normalized with the quantile method. In order
to identify differential expression, median FDRs of 0,17% and 0%
were considered for the SAM analysis of respectively mRNA and
miRNAs. Analyses on miRNAs and mRNAs were integrated in
relation to Pearson correlation gene expression.
Results
1. Ex vivo Assessments on Explanted Heart Valves
1.1 Macroscopic inspection. Prior to implantation, TRI-
COL aortic valvulated conduits exhibited patency and normal
morpho-anatomical characteristics (Figure 1A–B). All allografted
VPs (n = 11, Group A) demonstrated adequate hemodynamic
performance and proper implant growth, as sham animals (n = 4,
Group B) [23]. Explanted allografts showed normal appearance
without thrombi, vegetation, rupture or RV hypertrophy/aneur-
ysmatic dilatation (Figure 1C–D). Group A cusps were soft,
translucent and free from degenerations as those from Group B,
except two specimens (6 and 15 post-implantation months,
respectively) with mild thickening and sclerosis.
Calcification was detected at suture level in both experimental
groups.
1.2 Histological and immunophenotypical studies. In
allograft walls, histomorphological analyses, i.e. Heidenhain’s
Azan trichrome, elastic van Gieson and Alcian-PAS, revealed
appropriate ECM structure without rejection and/or degeneration
signs (e.g. elastic fiber fragmentation, fibrosis) or evidence of
increased interfibrillar space (Figure 2A–F and 2G–L respectively
for 6 and 15 months after implantation).
Focal dystrophic calcifications, i.e. single cells positive for von
Kossa and OC, interested anastomotic areas between recipient’s
pulmonary artery and donor’s decellularized aorta (Table S1 and
Figure S1 A, B and C for the immunophenotypical quantification
of cells populating respectively the intima, media and adventitia).
The allograft intimal layer was covered by a dense endothelial
lining, similarly to repositioned RVOTs (p =NS; Figures 3G and
S1A). In the endothelium layer, some myoendothelial elements
could be recognized for the expression of vWF and SMA.
Activated fibroblasts, positive for MyHCApla1, vimentin, OPN
and SMA, spread extensively in the media (p,0,05 in respect to
group B; Figures 3A–F, 3J–L and S1B). In comparison to sham
animals, fewer smoothelin-, calponin- and/or SM-MyHC-express-
ing SMCs were found, mostly populating neovascularized medial
regions (p,0,05; Figures 3M–R and S1B).
Already after 6 months, a rich medial capillary network was
present and at last explanttime, both media and adventitia displayed
newly re-formed, mature vasa vasorum (vWF-expressing endothelial
lumen and SMA-, smoothelin- and calponin-positive arteriolar
wall) (Figures 3H–I, K–L, N–O and Q-R, as well as S1B and C).
Procollagen-I synthesis was detected in cells colonizing the
allograft, more than in those populating the autograft (p,0,05;
Figure S1A, B and C). A progressive decrease in expression of
CD29, CD34, CD105, SSEA4 and OCT4 was observed during
time in both groups, with a significant permanence of stem cell
epitopes, mainly of mesenchymal, embryonic and neural lineages,
in the 15-month allografted wall (p,0,05; Figure S1A, B and C).
In Group A, a slight intimal thickening could be observed.
In allograft cusps, the original trilaminated structure was
preserved with intact elastic lamellae in ventricularis and regular
collagen and GAG distributions in spongiosa and fibrosa (Figures 2F–
H and J–L, 4A, G and H). No calcifications were apparent
(Figure 4B, C) and inflammatory infiltration could be revealed
only by minimal CD45 immunodetection (Figure 4D, E), similarly
detected in sham tissues (p =NS; Figure S1D).
Most cusps were completely re-endothelialized (Figure 4I), apart
for 3 non-coronary cases, one after 6 and two after 15 months,
with partial coverage and platelet attachment.
Fibroblast migration patterns interested leaflet base towards free
middle and distal portions. In one case at 6 implantation months
and in most samples at the last observation time, the interstitium was
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repopulated by many OPN, MyHCApla1, vimentin, SMA and
smoothelin-positive cells with analogous distribution to a native
leaflet (Figure 4J–N; Figure S1D; for comparison to a native tissue,
see [25]). In respect to B group, recellularized regions showed
higher expressions of embryonic (p,0,05), mesenchymal (mainly
p =NS) and neural (p =NS) stem cell markers, with furthermost
topographic location in the ventricularis layer (Figures 4O–Q and
S1D).
In comparison to group A, autografts displayed a lower number
of CD68-, OPN- and IL-10-positive cells (often p,0,05; Figure
S1D), known as M2 macrophages possessing anti-inflammatory
and reparative properties. At 15 months, repositioned RVOTs
exhibited good cellular and ECM preservation with undetectable
degenerations (Figure S1D and Table S1 for a detailed statistical
comparison between groups A and B).
1.3 Allograft primary cell cultures. Primary cultures
(adventitiae, mediae and cusps) revealed two main morphological
phenotypes (respectively, Figure 5.I.A–C and E–G) similar to
SMCs or bone marrow-mesenchymal stem cells (Figure 5.I.D and
H respectively). Most media-extracted cells were positive for SMA,
MyHCApla1 and OPN, while modestly expressing smoothelin,
calponin and SM-MyHC (Figure 5.II.A–E, Table 1 for quantita-
tive description). Absence of porcine CD45-leukocytes and rare
OC detection were remarkable (Figure 5.II.F, Table 1). Some
myofibroblasts denoted immature phenotype for SSEA4, OCT4,
CD90 and predominantly CD29 expression (Figure 5.II.G–J,
Table 1).
1.4 Cell survival aspects. After 15 follow-up months,
engrafted cells were highly proliferating with about
53,69617,18% phospho-histone 3 (PH3)-positive cells in entire
regenerated walls, averaging single percentages of 45,18616,16%
in intima, 43,56624,65% in media and 72,33611,42% in adventitia
(Figure S2A–C). An intense mitotic activity interested allograft
cusps too (57,32610,31%) (Figure 4F).
Similarly to native valves, repopulated allografts rarely exhibited
TUNEL-positivity, i.e. 3,9262,57% cusp cells and 3,1761,31%
wall cells (2,3761,13%, 4,6361,81% and 2,5360,98% respec-
tively for intima, media and adventitia). Conversely, native cells in
Group B explants presented DNA fragmentation after 6 months,
returning to physiological levels at longer observation (not shown).
1.5 SEM ultrastructure. In both observational times, re-
endothelialization was nearly complete on leaflet and intimal
allograft surfaces with typical microvilli-rich EC phenotype
(Figure 6A–D and E-H for specimens at 6 months and 15 months
respectively). However, few samples at 6 months showed unusual
morphologies (not shown). Superficial fibrin depots or ECM
exposure were not detected.
Figure 1. Macroscopic appearance of TRICOL allogeneic aortic valve before and after implantation. Allogeneic substitutes
demonstrated similar gross morpho-anatomic structure to native valves without signs of leaflet fenestration, rupture or degeneration both after
decellularization (C–D) and explant at 15 months (C–D).
doi:10.1371/journal.pone.0099593.g001
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1.6 TEM ultrastructure. Since early follow-up intervals, the
luminal surface of allograft walls was covered by an almost
continuous monolayer of well-joined, flat ECs (Figure 7.I.A). A
15 mm-thick sub-endothelial fibrillin-rich layer was often detect-
able.
Figure 2. Histologic evaluation of explanted allografts. Panoramic (A and G: H&E, B and H: Elastic van-Gieson, C and I: Azan’s Heidenhain
trichrome, magnification: 5 cm) and close-up (D–F and J–L) allograft views respectively at 6 and 15 months after surgery: note trilaminated
arrangement with recipient’s repopulating cells on both leaflet sides, i.e. ventricularis (v) and fibrosa (f) (D–E, J–K: H? F and L: Elastic van-Gieson).
Magnifications: (A–C and G–I) 1 cm; (D) 500 mm; (E, F) 100 mm; (J) 700 mm; (K, L) 200 mm.
doi:10.1371/journal.pone.0099593.g002
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Figure 3. Immunohistochemical characterization of allograft walls at 15 months. Vimentin- and MyHCApla1-positive fibroblasts (A–F) with
broad SMA, rare smoothelin and calponin detection (G–O). Re-endothelialization was observed at the intimal layer (G). Novel mature arterioles and
capillaries were identified in adventitia and media (H, I, K, L, N, O, Q and R). Magnification: 100 mm.
doi:10.1371/journal.pone.0099593.g003
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The tunica media was populated by scarcely interconnected cells
showing dilated rough endoplasmic reticulum (Figure 7.I.B) and
figures of extracellular matrix neosynthesis consisting in irregular
indentations, enveloping elaunin fibers and the typical collagen
fibril-forming channels (Figure 7.I.C, D).
Spindle-shaped cells, abundant in actin myofilaments, occupied
interlaminar spaces (Figure 7.I.E). Neoangiogenic aspects were
evident in media and adventitia due to the presence of capillary
vessels, lined by a continuous endothelium endowed with
intercellular junctions (Figure 7.I.H, F inset). In these tunicae,
immunohistochemically detected nerve fibers exhibited the typical
features characterizing amyelinic fibers being surrounded in
groups by single Schwann cells (Figure 7.I.G and I).
Allograft cusp surfaces were covered by a continuous monolayer
of flattened endothelial-like cells anchored to a thin basal lamina
and showing immature tight junctions (Figure 7.II.A, B). An
additional 3–4 mm-thick layer of elastin fibers/fibrillin microfibrils
was often detectable underneath the regenerated endothelium
(Figure 7.II.B). Cuboidal ECs, containing prominent Golgi
apparatus and dilated rough endoplasmic reticulum, adhered to
the luminal surface of two allografts explanted after 6 and 15
months, respectively.
As in native valve leaflets, most cells populating the interstitium
unveiled fibroblast-like features (Figure 7.II.A, E) and were mixed
to others resembling myofibroblasts (Figure 7.II.C) or SMCs
(Figure 7.II.D). Most of these cells exhibited lots of collagen fibril-
forming channels (Figure 7.II.E) and lied in an ECM enriched by
maturing elauninic fibers, surrounded by fibrillin microfibrils
(Figure 7.II.E, F).
Nevertheless, some allograft portions were acellular or con-
tained apoptotic/degenerated cells and/or swelled collagen fibrils
(not shown).
B grafts showed well-preserved ECM fibrous components, but
marked suffering/apoptotic cells after 6 implantation months, with
restriction to ECs solely for the longer follow-up (not shown).
1.7 mRNA and miRNA profiles. Genes prevalently ex-
pressed in long-term regenerated arterial walls found involvement
in ECM binding, smooth muscle contraction and development, as
highly activated SM22-alpha (Figures 8 and 9A). Indeed, up-
regulation of CAPZA2, CAST, GPX1, MEF2D and RYR1
smooth muscle genes could be observed in allografts’ transcrip-
tome (Figure 8). Gene expression profiles were correlated to
immunohistochemical results to confirm neosynthesis of these
proteins and reduce eventual stabilizations in the improvement of
their half-life, resulting in endorsed genetically activated transcrip-
tion of ribosomal proteins (Figure 8).
Microarray analyses identified three informative clusters in
repopulated allograft leaflets (Figure 8; Table S2). Most up-
regulated genes were involved in cell proliferation (20,7%; p-value
2,65E-03) – especially endothelial (13,8%; p-value 7,1E-03) –,
cellular catabolic process (13,8%; p-value 2,58E-04), cellular
movement/response to protein stimulus (10,3%; p-value 5,84E-
03 and 8,83E-03) and response to hydrogen peroxide (10,3%; p-
value 3,78E-03) with peroxiredoxin I (PRX I) overexpression
(Figure 9A).
Down-regulated genes found involvement in aging (23,1%; p-
value 1,11E-03), response to stimuli (23, 1%; p-value 1,04E-03)
and wound healing (15,4%; p-value 8,49E-03) (Figure 9A; Table
S2).
Interestingly, MHC protein complex class was enriched in
down-regulated genes (9,1%; p-value 1,39E-02), indicating scarce
or null inflammatory/immune events (Table S2).
Mutual gene interactions and their miRNAs-dependent regu-
lation were considered to identify gene regulatory networks
engaged in graft’s cell repopulation (Figure 6). Remarkably,
vascular cells-related genes decidual protein induced by proges-
terone (DEPP) and OPN were up-regulated in recellularized
leaflets (Figure 9B). In association to OPN, the most intercon-
nected node in the analysis was FOS, i.e. FOS FBJ murine
Figure 4. Immunohistochemical profile of recellularized leaflets at 6 months. Undetectable calcifications (B, C) or immune rejections
against allogeneic tissues (D, E). Conserved trilaminated ECM architecture (A, G and H). Native-like EC (I) and VIC phenotypes (J–N). Stem cell markers
of mesenchymal (O) and embryonic (P and Q) lineages, mainly expressed in ventricularis. In (F), PH3-positive leaflet-colonizing cells. V = ventricularis;
f = fibrosa. Magnification: 200 mm.
doi:10.1371/journal.pone.0099593.g004
Table 1. Immunophenotype of primary cultures derived from explanted valve allografts.
Antigens Medial cells (%) Adventitial cells (%) VICs (%)
Pig CD45 ND 0,0060,01 0,0060,01
MyHC-Apla1 82,5165,30 87,0668,21 95,2661,93
Calponin 26,5763,69 11,3067,88 7,1160,97
SM-MyHC 28,1569,01 29,71613,61 5,0262,96
Smoothelin 31,0367,16 12,5666,15 3,4162,00
OPN 68,06616,33 63,41613,28 88,9167,02
OC 1,2560,18 1,0660,05 0,9860,23
SSEA4 15,8964,02 7,4165,38 20,2664,59
OCT4 7,0666,99 10,0664,45 29,9761,81
CD90 3,1062,01 1,1560,86 25,8062,22
CD29 74,3664,13 52,29622,78 88,30611,01
Legend: Percentage of antigen expression after normalization to counted nuclei. ND: not detectable.
Primary cultures extracted from explanted tissues at 15 months were characterized immunophenotypically for markers commonly expressed in inflammation (CD45),
SMCs and/or VICs (OPN, MyHC-Apla1, Calponin, SM-MyHC and smoothelin), calcification (OC) and stemness (SSEA4, OCT4, CD90 and CD29).
doi:10.1371/journal.pone.0099593.t001
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osteosarcoma viral oncogene homolog gene, regulator of cell
proliferation and differentiation (Figure 9B).
Protein synthesis and mRNA stability are extremely influenced
by miRNAs, e.g. short RNA sequences important modulators of
biological functions. miRNAs, directly FOS-associated, were miR-
504, miR-92a, ENSSSCT00000020005, miR-378, miR-220b and
ENSSSCT00000020296 (Figure 9B).
Discussion
The inability of current valve prostheses to grow condemns
pediatric patients with congenital heart defects to undergo
repeated surgical interventions aimed at restoring cardiac func-
tion, but unfavorably raising peri-operative mortality. Additional-
ly, a highly active calcium metabolism can seriously compromise
the durability of implanted bioprostheses in younger subjects [30].
The present comprehensive analysis proves the in vivo promising
self-regeneration abilities of TRICOL allogeneic replacements in
15 follow-up months of hemodynamic and biological performance.
For critical assessment of RVOT reconstruction over time, the
VP’s slow somatic growth demonstrates the reliability of such an
animal model in simulating a developing juvenile human being
[23].
Porcine valve architecture and biomechanical strength are
unaffected by TRICOL decellularization [18–22], providing
eligibility to adequate hemodynamic profile in vivo. Noteworthy,
sulfated GAG and DNA contents in explants at 15 months are
comparable to native conditions [23].
In the present ex vivo investigation, histopathological, transcrip-
tomic, ultrastructural and immunophenotypical profiles of im-
planted decellularized allogeneic heart valves were carefully
examined after a long-term TEHV preclinical model. No
inflammation, rejection and/or calcification were observed in
allograft tissues, apart from mineralization circumscribed only to
Figure 5. Morphological and immunophenotypical analyses of primary cultures from 15-month regenerated allogeneic walls. I. Two
main morphologies could be observed during culturing medial cells: a cell line more elongated reaching confluence with hill and valley distribution
(A, B and C) and another one characterized by spindle-shaped cells growing in clusters (E, F and G). Such morphological aspects revealed a fine
analogy of these two primary cells respectively to mature artery SMCs (D) and bone marrow mesenchymal stem cells (H), both of porcine origin.
Magnifications: (A, E) 150 mm, (B, F) 100 mm, (C, D, G, H) 50 mm. II. Immunophenotype of primary cultures from 15-month regenerated allogeneic
walls. Wide FITC-conjugated SMA-positivity (green), less usual co-immunodetection with smoothelin or SM-MyHC (in red) (A–E), rare OC positivity (F),
extensive CD29 expression (J) in contrast to SSEA4, OCT4 and CD90 (G–I) (in green). Magnification: 30 mm.
doi:10.1371/journal.pone.0099593.g005
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anastomotic regions in both allografts and autografts. In previous
independent echocardiographic analyses, Steinhoff and Hopkins
similarly reported evident hyperechogenic areas in subvalvular
muscle areas, as pro-inflammatory/pro-calcific effects of the
surgical injury itself [9,11] rather than associated to structural
deterioration.
Endothelial molecular pathways were activated on implanted
allogeneic tissues, as shown by up-regulated genes involved in EC
functions. Outstandingly, OPN, DEPP and FOS share specific
expression in ECs, improving their migration, adhesion, prolifer-
ation and protection from dysfunction [31–33]. As a result of this
complex molecular activation, all surfaces exposed to recipient’s
blood were re-endothelialized. Allograft intima was also inhabited
by vWF- and SMA-positive myoendothelial progenitors, early
transitional stage of SMC differentiation in arterial embryogenesis
[34]. Microarray analyses and immunophenotypical characteriza-
tion on primary cell cultures of allograft walls confirmed gradual
loss of stem cell markers for the progressive acquisition of SM22,
inducing filamentous actin bundling, as well as of other contractile
smooth muscle proteins, necessary to sustain the differentiated
vascular phenotype [35]. Indeed, up-regulated miRNAs, like miR-
504, influenced cell cycle, angiogenesis control and functional
Figure 6. Scanning electron microscopy on allograft cusps at 6
and 15 implantation months. Almost complete endothelial
coverage (blue), progressive EC acquisition of surface microvilli (purple)
and no platelet aggregation onto fibrosa (green; at 6 months in A–B,
after 15 months in E–F) and ventricularis (green; at 6 months in C–D,
after 15 months in G–H). Note the absence of fibrin deposition, as well
as no red cell (red) entrapment in H. Magnifications: (A) 20 mm; (B, D, F,
H) 5 mm; (C, E, G) 10 mm.
doi:10.1371/journal.pone.0099593.g006
Figure 7. Transmission electron microscopy on allograft walls.
ECs covering intimal surface (A); underneath the intima, fibroblasts (Fbs)
with dilated endoplasmic reticulum (B; asterisks), synthesizing collagen
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remodelling of implanted tissues. A dynamic fibroblast engraft-
ment interested over time both cusps and walls, especially the
adventitial tunica, as assessed by immunohistochemistry on tissues
and primary cultures. The high expression of OPN shown by the
VIC- and SMC-like cells repopulating the allografts is very similar
to that observed in healthy heart valve tissues and likely ensures
protective effects against calcific events [25].
Hallmarks of on-going ECM neosynthesis were prominent in
leaflet and wall fibroblasts, as evidenced by procollagen I-
immunodetection and many, ultrastructurally revealed fibril-
forming channels and fibrillin microfibrils-surrounded elaunin
fibers.
Since first implantation months, neoangiogenesis/vasculariza-
tion phenomena, molecularly boosted by up-regulated miRNAs,
e.g. miR-92a [36], interested allograft walls with organization in
mature capillaries and vasa vasorum, well-documented immunohis-
tochemically and ultrastructurally. New blood vessels might have
developed from original vasculature’s ECM scaffolding preserved
during decellularization, as well as sprouted from vasa vasorum
supplying the anastomosed recipient’s pulmonary wall. The
resulting oxygenation and nutrient provision in implanted matrices
is likely to have further improved tissue viability and remodeling,
as evidenced by the high survival rate detected in all homed cells.
Observed miRNAs and PRX I overexpression correlates to this
increased cell survival, indicating that this up-regulation should
prevent apoptosis by scavenging reactive oxygen species [37–39].
Putative signs of novel vegetative innervation, i.e. immunohis-
tochemically and ultrastructurally identified nerve fibers in
adventitia and media, further indicate potential functionality
associated to tissue remodeling. As for neovasculature, re-
innervation might have regenerated from preserved ECM of
original nerve fibers [40].
Apparently, TRICOL scaffolds are providing a suitable
regeneration niche, where recipient’s cells could reside and
participate to proper tissue restoration. As further confirmation,
many M2-polarized macrophages were found concurring to such
regeneration process [41]. The morphological and immunocyto-
chemical characterizations of the primary cultures obtained from
explanted tissues, consistent with the transcriptomic results and
tissue observations, allow inferring the nature of the engrafting cell
sources, i.e. two different phenotypes with high resemblance to
mesenchymal stem cells of bone marrow origin and SMCs. Hence,
the repopulation phenomenon might have resulted from a
systemic bone marrow cell mobilization and a local smooth
muscle cell spreading from the adjacent anastomosed pulmonary
artery. Actually, the first event is promoted after any surgical
intervention: a facilitated diffusion of cytokines and growth factors
had likely contributed to the creation of new blood vessels and
favored the recruitment/motility of neighboring SMCs [42].
Although engrafted cells acquired a migrating phenotype during
observation, some allografts exhibited incomplete re-endotheliali-
zation and repopulation. Such conditions might be ascribed to
both pre- and post-implant complications, besides to in vivo
mechanical stress/insults, as for non-coronary leaflets [43,44],
fibrils from fibril-forming channels (C) and elastin fibers (e) (D) or with
abundant myofilaments (mf) (E). Erythrocytes (Er)-containing capillaries
coated by ECs joined by tight junctions (opposite arrowhead in inset)
(F). Amyelinic nerve fibers (NF) encapsulated by Schwann cells (SC) (G).
Blood vessels (arrows) in media and adventitia after trichrome staining
(H). Neural marker PGP9.5-expressing nerve fiber (arrows) in media (I).
Magnifications in I: A 3 mm; B 1 mm; C, D, G 0,5 mm; E, F inset 0,25 mm; F
2 mm; H, I 250 mm. Transmission electron microscopy on allograft
cusps. ECs onto intimal surface and sub-intimal Fbs (A). Immature
intercellular junction (opposite arrowheads) between ECs adhering
elauninic fibers (ef) surrounded by fibrillin microfibrils (encircled area)
(B). Interstitial myofibroblasts showing intercellular junctions (opposite
arrowheads) (C). Interstitial SMCs containing microfilaments (Mf) (D).
Fbs with multiple fibril-forming channels (arrow) and adjacent efs (E).
Abundant efs in interstitium (F). Magnifications in II: A 3 mm; B, C, E
0,5 mm; D, F 1 mm.
doi:10.1371/journal.pone.0099593.g007
Figure 8. Gene expression profiles at 15 months post-
implantation. Heat map of differentially expressed genes: Colors
based on logarithmic against averaged gene expressions. Green: down-
regulated genes; red: up-regulated ones. A.L.: Allograft Leaflet; B.L.:
Autograft Leaflet; A.W.: Allograft wall; L.A.: Left Atrium; L.V.: Left
Ventricle.
doi:10.1371/journal.pone.0099593.g008
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and/or transient hypoxic conditions during explant procedures,
since suffering cells were also noticed in autografts. TRICOL
treatment grants preservation of the adult basal lamina [18,19].
Nonetheless, a differential detergent sensitivity of tissues with
diverse post-natal developmental ages cannot be excluded and is
yet an unaddressed appraisal for TEHV approaches based on
pediatric tissues.
Figure 9. Gene expression profiles at 15 months post-implantation. Histograms representing enriched Gene Ontology terms for clusters 1, 3,
4 (green and red bars) and 2 (blue bars). P-value #0,05 (A). Gene interaction network derived from STRING database analysis of up- and down-
regulated genes on A.L. tissues (clusters 1, 3, 4). Pink nodes with grey border connect elements between up- or down-regulated nodes in analyzed
clusters. Central color node: gene expression in A.L. tissues; border: B.L. tissues. Yellow edges link connected nodes, while blue edges those altered in
analyzed clusters. Purple gene names represent relevant nodes according to Centiscape algorithm. *Genes discussed in the text (B).
doi:10.1371/journal.pone.0099593.g009
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Reported outcomes on their biological performance revealed
TRICOL heart valve scaffolds as suitable tissue-guided self-
regenerating replacements. The ability to instruct cells to a correct
differentiated function can be expected only from an integral
ECM, providing specific matrikine signaling for their homing,
integration and acquisition of specific phenotypes. TRICOL
substitutes do not elicit graft-versus-host disease and can sustain
cell repopulation and ECM remodeling for graft adaptation to
cardiac hemodynamics and somatic development.
Results from the present study fully support the concept of
in vivo spontaneous guided tissue regeneration, conditioning
decellularized valve allografts to viable and functional autolo-
gous-like replacements. Long-term outcomes observed for TRI-
COL aortic grafts in RVOT reconstruction are also encouraging
allogeneic human clinical trials based on a similar rationale,
overcoming the current paucity of pediatric size-pulmonary
allografts. Plus, as alpha-gal free replacements, they foster
human-like xenogeneic animal models to launch a new surgical
therapeutic era, based on more physiological alternatives espe-
cially for pediatric patients.
Supporting Information
Figure S1 Quantitative immunophenotypical profile of
allografted and autografted heart valves at 15 months
from implantation. For each antigen, expression has been
considered in allograft (A, dot pattern) and in autograft (B, stripe
pattern). Calcifying cells (von Kossa and OC), inflammatory and
immune cell markers (CD45, Mast cells, CD68 and IL-10), EC
markers (vWf and CD31), other vascular differentiated cell
epitopes (MyHC-Apla1, vimentin, OPN, SMA, Calponin, smooth-
elin and SM-MyHC), ECM synthetizing cells (Pro-collagen I),
haematopoietic stem cells (CD34 and CD117), mesenchymal stem
cells (CD29, CD90 and CD105), embryonic stem cells (SSEA4
and OCT4) and neural stem cells (NGFr, GFAP and Nestin) are
identified respectively by the shades of bordeaux red, dark blue,
olive green, purple, orange, light blue, red, light green and black.
In a., note the graphical elaboration for the intima, in b. for the
media, in c. for the adventitia and in d. for the leaflet.
(DOC)
Figure S2 Proliferative processes on allograft walls.
Note the high positivity and widespread distribution of PH3 in
intima (A), media (B) and especially adventitia (C). Magnification
100 mm.
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Table S1 Quantitative analyses on explanted decellularized
aortic allografts and autogeneic RVOTs after 15 months of follow-
up.
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Table S2 Up- and- down-regulated genes in biological processes
and cell components of valve allografts after 15 months.
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